Transcriptome analyses of ZRSR2-depleted cells and bone marrow samples from MDS patients with ZRSR2 mutations revealed an increase in retention of U12-type introns, while U2-type introns remained largely unaffected [19,20,21]. This evidence concerns the gene ZRSR2 and myelodysplastic syndrome.